IL104074A - 20-methyl-substituted vitamin d derivatives and process for the preparation thereof - Google Patents

20-methyl-substituted vitamin d derivatives and process for the preparation thereof

Info

Publication number
IL104074A
IL104074A IL104074A IL10407492A IL104074A IL 104074 A IL104074 A IL 104074A IL 104074 A IL104074 A IL 104074A IL 10407492 A IL10407492 A IL 10407492A IL 104074 A IL104074 A IL 104074A
Authority
IL
Israel
Prior art keywords
methyl
group
vitamin
dihydroxy
hydroxy
Prior art date
Application number
IL104074A
Other languages
English (en)
Other versions
IL104074A0 (en
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of IL104074A0 publication Critical patent/IL104074A0/xx
Publication of IL104074A publication Critical patent/IL104074A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL104074A 1991-12-13 1992-12-13 20-methyl-substituted vitamin d derivatives and process for the preparation thereof IL104074A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4141746A DE4141746A1 (de) 1991-12-13 1991-12-13 20-methyl-substituierte vitamin d-derivate

Publications (2)

Publication Number Publication Date
IL104074A0 IL104074A0 (en) 1993-05-13
IL104074A true IL104074A (en) 1998-01-04

Family

ID=6447341

Family Applications (1)

Application Number Title Priority Date Filing Date
IL104074A IL104074A (en) 1991-12-13 1992-12-13 20-methyl-substituted vitamin d derivatives and process for the preparation thereof

Country Status (24)

Country Link
US (1) US5446035A (cs)
EP (1) EP0637299B1 (cs)
JP (1) JP3280975B2 (cs)
KR (1) KR100271462B1 (cs)
CN (1) CN1035177C (cs)
AT (1) ATE138366T1 (cs)
AU (1) AU670585B2 (cs)
CA (1) CA2125476C (cs)
CZ (1) CZ286579B6 (cs)
DE (2) DE4141746A1 (cs)
DK (1) DK0637299T3 (cs)
ES (1) ES2089585T3 (cs)
FI (1) FI108226B (cs)
GR (1) GR3020097T3 (cs)
HU (1) HUT68263A (cs)
IL (1) IL104074A (cs)
MX (1) MX9207101A (cs)
NO (1) NO305949B1 (cs)
NZ (1) NZ246052A (cs)
PL (1) PL171403B1 (cs)
SK (1) SK280450B6 (cs)
TW (1) TW275060B (cs)
WO (1) WO1993012081A1 (cs)
ZA (1) ZA929650B (cs)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4220757A1 (de) * 1992-06-24 1994-01-05 Schering Ag Derivate in der Vitamin D-Reihe mit Modifikationen in der 20-Position, Verfahren zu ihrer Herstellung, Zwischenprodukte für dieses Verfahren, diese Derivate enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln
GB9220272D0 (en) * 1992-09-25 1992-11-11 Leo Pharm Prod Ltd Chemical compounds
IL107185A (en) * 1992-10-06 1998-02-22 Schering Ag Vitamin d, 25-carboxylic acid derivatives and pharmaceutical compositions containing the same
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
US20040167106A1 (en) * 1993-06-04 2004-08-26 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of a Vitamin D compound
GB9315253D0 (en) * 1993-07-23 1993-09-08 Res Inst Medicine Chem Chemical compounds
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
US5981597A (en) * 1995-02-13 1999-11-09 Trustees Of The University Of Pennsylvania Differentiating agents for the treatment of inflammatory intestinal diseases
ES2243978T3 (es) * 1996-02-13 2005-12-01 G.D. SEARLE & CO. Composiciones que comprenden un inhibidor de la ciclooxigenasa-2 y un antagonista del receptor de leucotrieno b4.
DE19619036A1 (de) 1996-04-30 1997-11-13 Schering Ag Neue Vitamin D-Derivate mit carbo- oder heterocyclischen Substituenten an C-25, Verfahren zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln
SG70010A1 (en) * 1996-05-23 2000-01-25 Hoffmann La Roche Fluorinated vitamin d3 analogs
US6028064A (en) 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6034074A (en) * 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
DE69814109T2 (de) * 1997-09-08 2004-02-26 F. Hoffmann-La Roche Ag 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analoga
ES2368824T3 (es) 1998-03-27 2011-11-22 Oregon Health & Science University Vitamina d y sus análogos en el tratamiento de tumores y otros desórdenes hiperproliferativos.
US6443856B1 (en) 1999-11-01 2002-09-03 Callaway Golf Company Contoured scorelines for the face of a golf club
US20030188756A1 (en) * 2002-08-19 2003-10-09 Cantorna Margherita T Treatment of inflammatory bowel disease with vitamin d compounds
US6358939B1 (en) 1999-12-21 2002-03-19 Northern Lights Pharmaceuticals, Llc Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease
US6989377B2 (en) 1999-12-21 2006-01-24 Wisconsin Alumni Research Foundation Treating vitamin D responsive diseases
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
EP1314427A4 (en) * 2000-08-17 2006-05-03 Chugai Pharmaceutical Co Ltd THERAPEUTIC AGENT FOR THE TREATMENT OF OSTEOPOROSIS
TWI329105B (en) * 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
US7122542B2 (en) 2003-07-30 2006-10-17 Rigel Pharmaceuticals, Inc. Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
NZ563270A (en) * 2005-05-10 2010-11-26 Dermipsor Ltd Calcipotriol, polyethylene oxide topical compositions for the treatment of hyperproliferative epidermal diseases
EP1879449A4 (en) * 2005-05-10 2009-12-16 Dermipsor Ltd SKIN CARE COMPOSITIONS AND METHODS
JP2008543855A (ja) 2005-06-13 2008-12-04 ライジェル ファーマシューティカルズ， インコーポレイテッド 変形性骨疾患を処置するための方法および組成物
PL1734251T3 (pl) * 2005-06-17 2007-05-31 Magneti Marelli Powertrain Spa Wtryskiwacz paliwa
AU2007287263A1 (en) * 2006-04-10 2008-02-28 Wisconsin Alumni Research Foundation Lalpha-hydroxy-2- (3 ' -hydroxypropylidene) -19-nor- vitamin D compounds with a 1,1-dimethylpropyl side chain
CA2838089A1 (en) 2006-08-25 2008-02-28 Cougar Biotechnology, Inc. Methods for treating cancer comprising the administration of a vitamin d compound and an additional therapeutic agent, and compositions containing the same
US20080051380A1 (en) * 2006-08-25 2008-02-28 Auerbach Alan H Methods and compositions for treating cancer
US20080051375A1 (en) * 2006-08-25 2008-02-28 Auerbach Alan H Methods for treating cancer comprising the administration of a vitamin d compound and an additional therapeutic agent, and compositions containing the same
WO2009009132A1 (en) * 2007-07-12 2009-01-15 Cougar Biotechnology, Inc. Use of 17alpha-hydroxylase/c17, 20-lyase inhibitors for the treatment of cancer
US20100196308A1 (en) * 2009-01-27 2010-08-05 Jimenez Joaquin J Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy
SG10201404883YA (en) 2009-08-14 2014-10-30 Berg Llc Vitamin d3 and analogs thereof for treating alopecia
US20190183908A1 (en) 2016-05-13 2019-06-20 Case Western Reserve University Autophagy activators for treating or preventing skin injury
AU2017302660B2 (en) 2016-07-29 2023-04-20 Janssen Pharmaceutica Nv Methods of treating prostate cancer
US10548908B2 (en) * 2016-09-15 2020-02-04 Nostopharma, LLC Compositions and methods for preventing and treating heterotopic ossification and pathologic calcification
US11903952B2 (en) 2020-05-27 2024-02-20 Northwestern University Vitamin D as an immune modulator to prevent immune-related complication from COVID-19 infection

Also Published As

Publication number Publication date
AU670585B2 (en) 1996-07-25
CN1035177C (zh) 1997-06-18
FI942766A7 (fi) 1994-06-10
JPH07505132A (ja) 1995-06-08
CA2125476A1 (en) 1993-06-24
NO942178L (cs) 1994-06-10
ATE138366T1 (de) 1996-06-15
AU4035693A (en) 1993-07-19
CN1073677A (zh) 1993-06-30
ES2089585T3 (es) 1996-10-01
SK280450B6 (sk) 2000-02-14
EP0637299B1 (de) 1996-05-22
HU9401456D0 (en) 1994-08-29
IL104074A0 (en) 1993-05-13
FI942766A0 (fi) 1994-06-10
KR100271462B1 (ko) 2000-11-15
DE59206393D1 (de) 1996-06-27
NZ246052A (en) 1995-07-26
ZA929650B (en) 1993-06-09
WO1993012081A1 (de) 1993-06-24
US5446035A (en) 1995-08-29
EP0637299A1 (de) 1995-02-08
DK0637299T3 (da) 1996-09-30
JP3280975B2 (ja) 2002-05-13
NO305949B1 (no) 1999-08-23
HUT68263A (en) 1995-06-28
CZ141694A3 (en) 1995-01-18
TW275060B (cs) 1996-05-01
CZ286579B6 (cs) 2000-05-17
FI108226B (fi) 2001-12-14
SK66194A3 (en) 1995-02-08
DE4141746A1 (de) 1993-06-17
MX9207101A (es) 1993-08-01
PL171403B1 (pl) 1997-04-30
NO942178D0 (no) 1994-06-10
CA2125476C (en) 2003-02-11
KR940703806A (ko) 1994-12-12
GR3020097T3 (en) 1996-08-31

Similar Documents

Publication Publication Date Title
US5446035A (en) 20-methyl-substituted vitamin D derivatives
US5532391A (en) Homologated vitamin D2 compounds and the corresponding 1α-hydroxylated derivatives
US4717721A (en) Sidechain homo-vitamin D compounds with preferential anti-cancer activity
US5552392A (en) Method of treating hypoparathyroidism with (20S) vitamin D compounds
US5545633A (en) 17-ene vitamine D analogues
CA2146429C (en) 25-carboxylic acid derivatives in the vitamin d series, method of producing them, intermediate products for this method, pharmaceutical preparations containing these derivatives and their use in the manufacture of medicines
KR100321414B1 (ko) 비타민d아미드유도체
CA2026671C (en) 24-homo vitamin d derivatives, process for their production and pharmaceutical preparations obtained therefrom
RU2128168C1 (ru) Аналоги витамина d3, способы из получения, фармацевтическая композиция и способ лечения
US5532228A (en) Side-chain homologous vitamin D derivatives, process for their production, pharmaceutical preparations containing these derivatives and their use as pharmaceutical agents
CA2224440A1 (en) New vitamin d derivatives with substituents at c-25, process for their production, intermediate products and use for the production of pharmaceutical agents
JP3779991B2 (ja) ビタミンｄアミンおよびアミド誘導体
US4857518A (en) Hydroxylated 24-homo-vitamin D derivatives and methods for preparing same
NZ319819A (en) Calcitriol derivatives and their uses
RU2183622C2 (ru) Аналоги витамина d, способ их получения, фармацевтическая комопзиция
US5994332A (en) Vitamin D analogues
CA2058637A1 (en) Side-chain homologous vitamin d derivatives, process for their production, pharmaceutical preparations containing these derivatives and their use as pharmaceutical agents
RU2175318C2 (ru) Производные витамина d3, способы его получения, фармацевтическая композиция
EP0218714B1 (en) Seco-sterol compounds effective in inducing the differentiation of malignant cells
IE850520L (en) 1ó-hydroxy vitamin d2 analogues
JP2003519682A (ja) 新規ビタミンｄ類似体
DE4445045A1 (de) 20-Fluor-substituierte Vitamin D-Derivate, Verfahren zu deren Herstellung, deren Verwendung zur Herstellung von Arzneimitteln und Zwischenprodukte zur Darstellung der Verbindungen

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees